The Phase II project of the Feiman Bio Changchun Jingyue Factory, undertaken by the Group Company, has officially commenced.

Release time:

2026-04-29

The Phase II project of the Feiman Bio Changchun Jingyue Factory, undertaken by the Group Company, has officially commenced construction.

On April 28, a grand groundbreaking ceremony was held for the Phase II project of the Feiman Bio Changchun Jingyue Factory, which is being constructed by the Group. Zhang Jian, General Manager of the company, Xu Bing, Deputy General Manager, and other senior executives attended the ceremony.

This project is being developed under an engineering, procurement, and construction (EPC) contracting model, with a planned gross floor area exceeding 20,000 square meters and a contract value of more than RMB 200 million. Construction is being undertaken by the Group’s Jinhui Branch. Leveraging Feiman Bio’s technological breakthroughs in the field of active collagen, the project will establish a full-industry-chain ecosystem spanning research and development to production, with the aim of setting a benchmark for the biopharmaceutical industry. At the groundbreaking ceremony, General Manager Zhang Jian delivered a speech, stating that Jiangsu Qian’an will fully leverage its expertise in pharmaceutical infrastructure construction, honor its commitments through pragmatic action, and reciprocate the trust placed in it with uncompromising quality. Mr. Zhang urged the project team to spare no effort in creating greater value for the client, ensuring the project’s high-quality execution, and ushering in a new chapter of mutually beneficial cooperation between the two parties. The successful commencement ceremony marks the entry of Jiangsu Qian’an’s collaboration with Feiman Biotechnology into a new phase, while also underscoring Jiangsu Qian’an’s professional expertise and technological strengths in the pharmaceutical infrastructure sector. Moving forward, the two parties will leverage this project as a strategic link to further deepen their cooperation, jointly driving innovation and development in the biopharmaceutical and medical aesthetics industries, and contributing to regional economic growth and industry advancement. (Jinhui Branch)

Group Labor Service Company Holds 2026 Annual Labor Management Work Conference

The Group’s Pudong Airport West Cargo Area Integrated Energy Station Project Has Undergone Completion Acceptance and Been Delivered for Use.

Recommended news

2026-09-18

Benchmarking against global standards! The Jotun Zhangjiagang project has successfully passed the safety audit conducted by its Norwegian headquarters.

In mid-September, a foreign‑owned owner‑audit expert team from Jotun’s Norwegian headquarters conducted a three‑day, headquarter‑level specialized safety audit at the Jotun Zhangjiagang project site undertaken by the Group.

2026-09-18

The Roche (Shanghai) project of the Group has successfully achieved 2 million safe man-hours.

On September 17, the Roche (Shanghai) Biopharmaceutical Production Base project, undertaken by the Group, successfully reached the milestone of 2 million safe man-hours.

2026-09-18

The Group dispatched personnel to attend the training on building trustworthy quality teams in chemical engineering construction.

On September 16–17, the China Chemical Construction Enterprises Association held a training course on building “Quality‑Trusted Work Teams” in Chengdu, with representatives from the Group in attendance. The training featured a live lecture by Shi Jie, a senior expert of the Association.

2026-09-09

Good News Abounds | The Group Has Secured Multiple Emerging Industry Projects in Succession

In the golden autumn season, bountiful harvests abound, and new‑generation growth sectors showcase their strength. Since August, leveraging its deep-rooted expertise and core competencies in industrial installation, the Group has successively won bids for five key projects in emerging productivity fields, with a total contract value exceeding RMB 250 million, injecting robust momentum into its resilient year‑end performance.

2026-09-03

Two QC achievements of the Group have been awarded at the National Engineering Construction Quality Management Achievement Competition.

Recently, the China Construction Industry Association announced the results of the 2026 Engineering Construction Quality Management Team Achievement Competition. Two QC projects submitted by the Group—“Improving the First-Pass Acceptance Rate for One-Time Forming of Exterior Concrete Moldings” and “Enhancing the First-Pass Welding Acceptance Rate for Dissimilar Steels”—were awarded second and third prizes, respectively.

2026-09-01

The Group convened a special meeting to study and implement the spirit of the branch‑company representatives’ symposium.

On the afternoon of August 31, the Group convened a meeting of heads of regional companies and departmental offices in the fourth-floor conference room at its headquarters to deliberate on the implementation of the spirit of the symposium for branch‑office representatives held by the Group on August 30.